These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6056038)

  • 1. Irreversible enzyme inhibitors. 103. 9-(p-Bromoacetamidophenyl)guanine, an irreversible inhibitor of xanthine oxidase.
    Baker BR; Wood WF
    J Med Chem; 1967 Nov; 10(6):1106-9. PubMed ID: 6056038
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible enzyme inhibitors. CII. On the mode of phenyl binding of 9-phenylguanine to guanine deaminase and xanthine oxidase.
    Baker BR; Wood WF
    J Med Chem; 1967 Nov; 10(6):1101-5. PubMed ID: 6056037
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific irreversible enzyme inhibitors.
    Baker BR
    Annu Rev Pharmacol; 1970; 10():35-50. PubMed ID: 4986559
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation analysis of Baker's studies on enzyme inhibition. 1. Guanine deaminase, xanthine oxidase, dihydrofolate reductase, and complement.
    Silipo C; Hansch C
    J Med Chem; 1976 Jan; 19(1):62-71. PubMed ID: 1246055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible enzyme inhibitors. CXLVII. Candidate active-site-directed irreversible inhibitors of xanthine oxidase derived from 9-(p-acylamidoalkoxyphenyl)guanines bearing a terminal sulfonyl fluoride.
    Baker BR; Wood WF
    J Med Chem; 1969 Mar; 12(2):214-6. PubMed ID: 5783592
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of fused [1,2,6]thiadiazine 1,1-dioxides as potential transition-state analogue inhibitors of xanthine oxidase and guanase.
    Meyer RB; Skibo EB
    J Med Chem; 1979 Aug; 22(8):944-8. PubMed ID: 490539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible enzyme inhibitors. 184. An affinity column for purification of rat liver guanine deaminase and xanthine oxidase.
    Baker BR; Siebeneick HU
    J Med Chem; 1971 Sep; 14(9):799-801. PubMed ID: 5140006
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 6,9-disubstituted 8-azapurines on adenosine deaminase, guanine deaminase and xanthine oxidase.
    Lucacchini A; Bazzichi L; Biagi G; Livi O; Segnini D
    Ital J Biochem; 1982; 31(3):153-62. PubMed ID: 6897062
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of substituted 1,2,3-triazoles on adenosine deaminase, guanine deaminase and xanthine oxidase.
    Lucacchini A; Segnini D; Da Settimo A; Livi O
    Ital J Biochem; 1979; 28(3):194-206. PubMed ID: 583599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible enzyme inhibitors. CXLVI. Active-site-directed irreversible inhibitors of xanthine oxidase derived from 9-(acylamidophenyl)guanines substituted with a terminal sulfonyl fluoride.
    Baker BR; Wood WF
    J Med Chem; 1969 Mar; 12(2):211-4. PubMed ID: 5783591
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible enzyme inhibitors. CXXV. Active-site-directed irreversible inhibitors of xanthine oxidase derived from arylpurines and pyrazolo[3,4-d]pyrimidines bearing a terminal sulfonyl fluoride.
    Baker BR; Kozma JA
    J Med Chem; 1968 Jul; 11(4):656-61. PubMed ID: 5671223
    [No Abstract]   [Full Text] [Related]  

  • 12. 3-Hydroxy-1-nitrophenyl-1(H-pyrazolo(3,4-b)pyridines as selective inhibitors of rat liver xanthine oxidase.
    Parmar SS; Pandey BR; Dwivedi C; Ali B
    J Med Chem; 1974 Sep; 17(9):1031-3. PubMed ID: 4416932
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective inhibition of xanthine oxidase by substituted pyridopyrimidines.
    Kaur S; Raman K; Pandey BR; Barthwal JP; Kishor K; Kumar A; Bhargava KP; Ali B
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):103-13. PubMed ID: 684270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible enzyme inhibitors. 148. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride.
    Baker BR; Wood WF
    J Med Chem; 1969 Mar; 12(2):216-20. PubMed ID: 5783593
    [No Abstract]   [Full Text] [Related]  

  • 15. The structure-activity relationship of 9-(X-phenyl)guanine inhibitors of xanthine oxidase.
    Silipo C; Hansch C
    Farmaco Sci; 1975 Jan; 30(1):35-46. PubMed ID: 1116591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and properties of the sulfonyl analogues of 4(5)-aminoimidazole-5(4)-carboxamide, 4(5)-(formylamino)imidazole-5(4)-carboxamide, guanine, and xanthine.
    Huang BS; Chello PL; Yip L; Parham JC
    J Med Chem; 1980 May; 23(5):575-7. PubMed ID: 6892931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible enzyme inhibitors. CXXVI. Hydrocarbon interaction with xanthine oxidase by phenyl substituents on purines and pyrazolo[3,4-d]pyrimidines.
    Baker BR; Wood WF; Kozma JA
    J Med Chem; 1968 Jul; 11(4):661-6. PubMed ID: 5671224
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzyme inhibitors. XX. Studies on the hydrophobic and hydroxyl binding regions of adenosine deaminase. 9-(2-m-Bromoacetamidophenethyl)adenine, a new irreversible inhibitor of adenosine deaminase.
    Schaeffer HJ; Johnson RN
    J Med Chem; 1968 Jan; 11(1):21-6. PubMed ID: 5637186
    [No Abstract]   [Full Text] [Related]  

  • 19. A powerful inhibitor of guanine deaminase.
    Lucacchini A; Montali U; Segnini D
    Ital J Biochem; 1977; 26(1):27-36. PubMed ID: 266488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of plumbous ion on guanine metabolism.
    Farkas WR; Stanawitz T
    J Inorg Biochem; 1979 Aug; 11(1):31-8. PubMed ID: 113506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.